[EN] ACLY INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS D'ACLY ET LEURS UTILISATIONS
申请人:NIMBUS ARTEMIS INC
公开号:WO2020097408A1
公开(公告)日:2020-05-14
The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.
本发明提供了作为ATP柠檬酸裂合酶(ACLY)抑制剂的化合物、其组合物以及使用方法。
IDO inhibitors
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10167254B2
公开(公告)日:2019-01-01
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
National Socialism and Literary Adaptation: Gustaf Gründgens’s Der Schritt vom Wege and Helmut Käutner’s Kleider Machen Leute
作者:Paul Coates
DOI:10.1111/1468-0483.00162
日期:2000.4
Eric Rentschler argues that ‘film production in the Third Reich offers a strikingly concrete example’ of the theoretical construct of ‘the dominant cinema’ (‘Hollywood’) devised by film theorists. But is the era of ‘Germany’s Hollywood’ ideological in the same way as Hollywood, or in a different way? Consideration of National Socialist adaptations of non‐Nazi texts may help one determine the specific meaning of the ideological in the Nazi context. The admittedly small area of National Socialist literary adaptation acquires a disproportionately revelatory potential due to the clearly perceptible disparities between the original, pre‐Nazi texts and their Nazi‐era reworkings. The adaptations considered here are Gustaf Gründgens’s Der Schritt vom Wege (1939), based on Fontane’s Effi Briest – a parti‐cularly problematic work for National Socialist ideology – and Helmut Käutner’s version of Gottfried Keller’s Kleider machen Leute (1940), whose admission of its own approximate relationship with the original narrative seems to dismiss the probably irresoluble problem of fidelity to the original, but which is also problematic.
IDO INHIBITORS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20170231999A1
公开(公告)日:2017-08-17
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
ACLY INHIBITORS AND USES THEREOF
申请人:Nimbus Artemis, Inc.
公开号:US20200148634A1
公开(公告)日:2020-05-14
The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.